Hedge funds are releasing their third quarter long holdings, and at least two big names are holding a bunch of Valeant Pharmaceutical stock — Leon Cooperman of Omega Advisors and John Paulson of Paulson & Co.
As of the end of the third quarter, Omega was holding 484,915 Valeant shares worth over $US86 million.
Paulson & Co. sold 110,000 shares of the stock in Q3, but is still holding about 8.9 million shares of the stock worth $US1.6 billion.
Valeant Pharmaceuticals’ stock has lost over 50% of its value over the last few weeks.
Revelations of shady dealings by its former partner specialty pharmacy — a pharmacy that distributes products and takes care of insurance billing for big drug companies — and state and federal investigations into the Valeant’s drug price increases have sent investors running for the exits.
Valeant shares closed Monday down 2.86%, at a price of $US73.29. At the start of the third quarter they were worth around $US232, they closed the quarter at $US178.
NOW WATCH: ‘Shark Tank’ star Robert Herjavec says only Americans think there are no opportunities in America
Business Insider Emails & Alerts
Site highlights each day to your inbox.